Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin. (Q52145169)

23 April 2018

title

Primary glioblastoma multiforme tumors and recurrence : Comparative analysis of the danger signals HMGB1, HSP70, and calreticulin. (English)

1 reference

23 April 2018

1 reference

5

1 reference

23 April 2018

Rainer Fietkau

8

object named as

Rainer Fietkau

1 reference

23 April 2018

Carolin Muth

1

1 reference

23 April 2018

Yvonne Rubner

2

1 reference

23 April 2018

Sabine Semrau

3

1 reference

23 April 2018

Paul-Friedrich Rühle

4

1 reference

23 April 2018

Annedore Strnad

6

1 reference

23 April 2018

Rolf Buslei

7

1 reference

23 April 2018

Udo S Gaipl

9

1 reference

23 April 2018

publication date

8 December 2015

1 reference

23 April 2018

Strahlentherapie und Onkologie

published in

1 reference

23 April 2018

volume

192

1 reference

23 April 2018

issue

3

1 reference

23 April 2018

page(s)

146-155

1 reference

23 April 2018

https://scigraph.springernature.com/pub.10.1007/s00066-015-0926-z

exact match

0 references

cites work

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Current challenges in designing GBM trials for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Type I Interferons as Stimulators of DC-Mediated Cross-Priming: Impact on Anti-Tumor Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Clinical evaluation of systemic and local immune responses in cancer: time for integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Vaccines for glioblastoma and high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Molecular characteristics of immunogenic cancer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Immunogenic cell death in radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Inflammation and cancer: a double-edged sword.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

The role of heat shock protein 70 (Hsp70) in radiation-induced immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Dual role of heat shock proteins (HSPs) in anti-tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Identification of diagnostic serum protein profiles of glioblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Towards developing biomarkers for glioblastoma multiforme: a proteomics view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Immunogenic cell death and DAMPs in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Reliability of HSP70 (HSPA) expression as a prognostic marker in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Dendritic cell therapy of high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

HMGB1 mediates endogenous TLR2 activation and brain tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Calreticulin expression in infiltrating ductal breast carcinomas: relationships with disease progression and humoral immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Calreticulin expression in neuroblastoma--a novel independent prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Sensitizing tumor cells to radiation by targeting the heat shock response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-015-0926-Z

Patient survival by Hsp70 membrane phenotype

21 January 2018

1 reference

12 December 2020

Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages

1 reference

12 December 2020

Calreticulin as a potential diagnostic biomarker for lung cancer

1 reference

12 December 2020

Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer

1 reference

12 December 2020

10.1007/S00066-015-0926-Z

Identifiers

DOI

1 reference

23 April 2018

PubMed ID

26646311

1 reference

23 April 2018